Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy

• Published in: Radiation oncology (London, England) Vol. 14; no. 1; p. 50
• Main Authors: Su, Ting-Shi, Yang, Hai-Ming, Zhou, Ying, Huang, Yong, Liang, Ping, Cheng, Tao, Chen, Long, Li, Le-Qun, Liang, Shi-Xiong
• Format: Journal Article
• Language: English
• Published: England BioMed Central 27.03.2019; BMC
• Subjects: Adult; Aged; Albumin; Albumin–bilirubin; Background radiation; Bilirubin; Bilirubin - blood; Biomarkers, Tumor - analysis; Biopsy; Cancer therapies; Carcinoma, Hepatocellular - blood; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - surgery; Child-Turcotte-Pugh; Classification; Dosimetry; Female; Hepatitis; Hepatocellular carcinoma; Humans; Liver; Liver cancer; Liver diseases; Liver Neoplasms - blood; Liver Neoplasms - pathology; Liver Neoplasms - surgery; Male; Medical prognosis; Middle Aged; Patients; Prognosis; Quality; Radiation; Radiation therapy; Radiosurgery - mortality; Retrospective Studies; Serum Albumin, Human - analysis; Severity of Illness Index; Stereotactic body radiation therapy; Survival; Survival analysis; Survival Rate; United States > US; Hepatocellular carcinoma; Albumin–bilirubin; Prognosis; Stereotactic body radiation therapy; Child-Turcotte-Pugh

Child-Turcotte-Pugh (CTP) score extensively used to assess hepatic function, predicting postoperative outcome of hepatocellular carcinoma (HCC) patients. Lately, the albumin-bilirubin (ALBI) grade has been identified to be a predictor of overall survival of HCC patients. In this investigation, we co...